Detection, Treatment, and Prevention of Clostridium difficile Infection

被引:48
|
作者
McCollum, David L. [1 ]
Rodriguez, J. Martin [1 ]
机构
[1] Univ Alabama Birmingham, Div Infect Dis, Birmingham, AL 35294 USA
关键词
Clostridium difficile Infection; Antimicrobial-Associated Diarrhea; Metronidazole; Vancomycin; Fidaxomicin; PROTON-PUMP INHIBITORS; VANCOMYCIN-RESISTANT ENTEROCOCCI; ANTIBIOTIC-ASSOCIATED DIARRHEA; HOSPITALIZED-PATIENTS; ORAL VANCOMYCIN; RISK-FACTORS; TOXIN-A; SACCHAROMYCES-BOULARDII; SIGNIFICANT ABSORPTION; STAPHYLOCOCCUS-AUREUS;
D O I
10.1016/j.cgh.2012.03.008
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Clostridium difficile is a gram-positive anaerobic bacillus responsible for approximately 1 of 5 cases of antibiotic-associated diarrhea. C difficile infection (CDI) is defined by at least 3 unformed stools in a 24-hour period and stool, endoscopic, or histopathologic test results that indicate the presence of this bacteria. The history of CDI research can be divided into early (before 2000) and modern eras (after 2000). C difficile was first described in 1935, and the characteristics and causes of CDI as well as therapies were identified during the early era of research. During the modern era, CDI has become a more common, aggressive nosocomial infection. Our understanding of the epidemiology, diagnosis, treatment, and prevention of CDI has increased at a rapid pace. We review features of CDI diagnosis, treatment, and prevention.
引用
收藏
页码:581 / 592
页数:12
相关论文
共 50 条
  • [1] Prevention and treatment of Clostridium difficile infection
    Gouliouris, Theodore
    Brown, Nicholas M.
    Aliyu, Sani H.
    [J]. CLINICAL MEDICINE, 2011, 11 (01) : 75 - 79
  • [2] Clostridium difficile Infection: Prevention and Treatment
    Barreto, Tyler W.
    Lin, Kenneth W.
    [J]. AMERICAN FAMILY PHYSICIAN, 2018, 97 (03) : 196 - 199
  • [3] Probiotics for Prevention and Treatment of Clostridium difficile Infection
    Valdes-Varela, Lorena
    Gueimonde, Miguel
    Ruas-Madiedo, Patricia
    [J]. UPDATES ON CLOSTRIDIUM DIFFICILE IN EUROPE: ADVANCES IN MICROBIOLOGY, INFECTIOUS DISEASES AND PUBLIC HEALTH, VOL 8, 2018, 1050 : 161 - 176
  • [4] Breakthroughs in the treatment and prevention of Clostridium difficile infection
    Larry K. Kociolek
    Dale N. Gerding
    [J]. Nature Reviews Gastroenterology & Hepatology, 2016, 13 : 150 - 160
  • [5] Breakthroughs in the treatment and prevention of Clostridium difficile infection
    Kociolek, Larry K.
    Gerding, Dale N.
    [J]. NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2016, 13 (03) : 150 - 160
  • [6] Clostridium Difficile Infection Prevention, Treatment, and Surgical Management
    Luciano, Jason A.
    Zuckerbraun, Brian S.
    [J]. SURGICAL CLINICS OF NORTH AMERICA, 2014, 94 (06) : 1335 - +
  • [7] Consensus on the prevention, diagnosis, and treatment of Clostridium difficile infection
    Abreu y Abreu, A. T.
    Velarde-Ruiz Velasco, J. A.
    Zavala-Solares, M. R.
    Remes-Troche, J. M.
    Carmona-Sanchez, R. I.
    Aldana-Ledesma, J. M.
    Camacho-Ortiz, A.
    Contreras-Omana, R.
    Diaz-Seoane, R.
    Elizondo-Vazquez, C. T.
    Garza-Gonzalez, E.
    Grajales-Figueroa, G.
    Gomez-Escudero, O.
    Jacobo-Karam, J. S.
    Morales-Arambula, M.
    Olivares-Guzman, L. O.
    Sifuentes-Osornio, J.
    Siu-Moguel, A. G.
    Soto-Solis, R.
    Valdovinos-Garcia, L. R.
    Valdovinos-Diaz, M. A.
    Vazquez-Elizondo, G.
    la Vega Jasso, S. A. Lazo-de
    [J]. REVISTA DE GASTROENTEROLOGIA DE MEXICO, 2019, 84 (02): : 204 - 219
  • [8] Clostridium difficile: Changing Epidemiology, Treatment and Infection Prevention Measures
    Jane A. Cecil
    [J]. Current Infectious Disease Reports, 2012, 14 : 612 - 619
  • [9] Recurrent Clostridium difficile Infection: Risk Factors, Treatment, and Prevention
    Song, Jung Hoon
    Kim, You Sun
    [J]. GUT AND LIVER, 2019, 13 (01) : 16 - 24
  • [10] Infection control and prevention of Clostridium difficile infection
    Worsley, MA
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 41 : 59 - 66